Elsevier

Neurobiology of Aging

Volume 107, November 2021, Pages 53-56
Neurobiology of Aging

Negative results
Lack of limbic-predominant age-related TDP-43 encephalopathy (LATE) neuropathological changes in aged macaques with memory impairment

https://doi.org/10.1016/j.neurobiolaging.2021.07.009Get rights and content

.Abstract

The neuropathological changes of limbic-predominant age-related TDP-43 encephalopathy (LATE) are frequent in the aged population and are now recognized as a cause of memory impairment. However, it remains unknown if this proteinopathy is also present in other primate species. We thus investigated the presence and distribution of TDP-43 pathology in the hippocampus and amygdala of 7 aged memory-impaired rhesus macaques (Macaca mulatta, 18–32 years old) from 2 different cohorts. While present in an FTLD-TDP case used as a positive control for immunostaining, we found no TDP-43 or phosphorylated TDP-43 immunoreactive neuronal cytoplasmic inclusion in the amygdala or the hippocampus of these aged animals (as well as in young and mature macaques used as negative controls). We concluded that LATE is probably a human-specific condition, such as many other proteinopathies, and does not participate in age-related memory impairment in non–human primates.

Introduction

Limbic-predominant age-related TDP-43 encephalopathy (LATE), and its underlying neuropathological changes (LATE-NC), are now recognized as a frequent proteinopathy in aged subjects (Nelson et al., 2019). LATE-NC are characterized by TAR DNA-binding protein 43 (TDP-43) inclusions primarily located in limbic regions (amygdala and hippocampus) that can be differentiated histologically from frontotemporal lobar degeneration with TDP-43 (FTLD-TDP) (Robinson et al., 2020). While LATE-NC may be co-morbid with Alzheimer's disease (AD) neuropathological changes, they can also be present in isolation and are often suspected in clinical practice in patients with amnesic syndrome and normal AD biomarkers (Besser et al., 2020; Nag et al., 2017). Given the lack of specific TDP-43 biomarkers, this clinical situation is also referred to as Suspected non–Alzheimer disease Pathophysiology (SNAP) (Jack et al., 2016).

Behavioral changes, including memory impairment, have frequently been reported in aged non–human primates (NHPs) species. However, the causes of these age-related behavioral changes are poorly explained in NHPs, mainly because researchers failed to detect true extensive AD tau pathology with neurodegeneration in these animals (Walker and Jucker, 2017). This situation in NHPs mimics the neurologic concept of SNAP. Thus, we hypothesized that aged rhesus macaques, presenting with memory impairment but no AD pathologic changes, may exhibit some lesions reminiscent of LATE-NC.

Section snippets

Aged animals and controls (Table 1)

Experiments were carried out in accordance with European Communities Council Directive of June 3, 2010 (2010/6106/EU) for care of laboratory animals in an Association for Assessment and Accreditation of Laboratory Animal Care–accredited facility. The Institute of Laboratory Animal Science ethical committee approved the procedures (Beijing, China).

Cohort 1 – First, the study was conducted using 3 male rhesus macaques (Macaca mulatta with known birthdates from certified breeding facilities;

Results

In these aged monkeys (Table 1), AD neuropathological changes in the hippocampus were ruled out by finding no hippocampal neurofibrillary tangles using a PHF-tau specific monoclonal antibody (AT8). Then, we determine whether TDP-43-associated hippocampal pathology may underlie the memory impairment observed in aged NHPs (reported in Schneider et al., 2013 and Supplementary Fig. 1). In the hippocampus of an FTLD-TDP patient, used as a positive control for immunostaining, we found neuronal

Discussion

In this study, we investigated the brains of aged rhesus macaques (18–32 years old) with overt memory impairments. As previously claimed (Walker and Jucker, 2017), we found no AD-like neurofibrillary tangles in the hippocampus of these NHPs. In this situation mimicking human SNAP, we failed to demonstrate any LATE-NC lesion, even in the amygdala, the earliest affected brain area in this condition (LATE-NC stage 1; Nelson et al., 2019). To the best of our knowledge, no study had looked for such

CRediT Authorship Contribution Statement

MD: Formal analysis of tissues, Investigation, Writing – original draft; MHC: Formal analysis of tissues; MB: Formal analysis of behavioral experiments; MLA: Formal analysis of tissues; MLQ: Formal analysis of tissues; BD: Resources Provision, Supervision; Writing – review & editing. EB: Resources Provision, Supervision; Project administration; Writing – review & editing; VP: Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review &

Disclosure statement

The authors declare no competing financial interests relative to the present study.

Acknowledgements

The authors want to thank Prof Marie-Laure Martin-Négrier (Department of Pathology, Bordeaux University Hospital) for providing them with FTLD-TDP tissue used as positive control in this study. VP received grants from Foundation Bettencourt Schueller (CCA-Inserm-Bettencourt). The sponsors did not participate in any aspect of the design or performance of the study, including data collection, management, data analysis, and the interpretation or preparation, review, and approval of the manuscript.

References (18)

There are more references available in the full text version of this article.

Cited by (4)

View full text